To explore the role of ROS in CD8+ T cell antitumor function, WT OT-I cells stimulated with anti-CD3 and anti-CD28 antibodies plus NAC in vitro were transferred into tumor-bearing mice. This evidence concerns the gene CD8A and neoplasm.